Can This Biotech Roar Past $300?

In the following video, Fool contributor Maxx Chatsko reviews the biggest catalysts for Regeneron's  (NASDAQ: REGN  ) recent climb and near-rendezvous with $300 per share. The emerging biotech powerhouse has treated investors well in recent years -- returning more than 1,200% since 2008. While the company no doubt has a promising future, investors may be curious if things are getting too hot too fast. Did investors overreact to prior developments this year? Are shares priced for perfection? Or is $300 per share a benchmark that is actually within reach? The key lies in the pipeline.

While looking at 2012 performance is useful, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.


Read/Post Comments (2) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On May 30, 2013, at 1:01 PM, maleo2112 wrote:

    why is a 12 year old giving a stock review when he can barely pronounce the generic names. seriously, is this an analyst or my next babysitter?

  • Report this Comment On May 30, 2013, at 3:18 PM, davidm9999 wrote:

    It could hit $350 or $395 possibly. I've been shorting this thing since $70 and it continues to shock me with its resilience - the numbers are horrible but it still manages to rise continuously

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2457406, ~/Articles/ArticleHandler.aspx, 10/30/2014 9:21:33 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement